Wrocław Medical University is an institution of higher medical education in Wrocław, Poland. It consists of five faculties: Medicine, Dentistry, Pharmacy, Public Health and Postgraduate Education. The total number of chairs and clinics is 107.

During the past decade, Wroclaw Medical University conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 5 clinical trials were completed, i.e. on average, 18.5% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 2 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wroclaw Medical University" #1 sponsor was "Wroclaw Medical University" with 13 trials, followed by "Celgene" with 3 trials sponsored, "Anergis" with 2 trials sponsored, "Medical University of Warsaw" with 2 trials sponsored and "Allergan" with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wroclaw Medical University" #1 collaborator was "Wroclaw Medical University" with 4 trials as a collaborator, "Medical University of Silesia" with 2 trials as a collaborator, "ASL Parma" with 1 trials as a collaborator, "Academy of Finland" with 1 trials as a collaborator and "Air Force Military Medical University, China" with 1 trials as a collaborator. Other collaborators include 57 different institutions and companies that were collaborators in the rest 67 trials.

According to Clinical.Site data, the most researched conditions in "Wroclaw Medical University" are "Crohn Disease" (3 trials), "Sleep Bruxism" (3 trials), "Temporomandibular Disorder" (3 trials), "Cardiovascular Diseases" (2 trials) and "Mental Status Change" (2 trials). Many other conditions were trialed in "Wroclaw Medical University" in a lesser frequency.

Most popular intervention types in "Wroclaw Medical University" are "Drug" (17 trials), "Other" (7 trials), "Procedure" (5 trials), "Biological" (4 trials) and "Diagnostic Test" (4 trials). Other intervention types were less common.

The name of intervention was led by "Ozanimod" (3 trials), "Cyclophosphamide" (2 trials), "Placebo" (2 trials), "Polysomnography" (2 trials) and "Acoramidis (AG10)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wroclaw Medical University" are 37 trials for "All" genders.

Currently, there are NaN active trials in "Wroclaw Medical University". undefined are not yet recruiting, 7 are recruiting, 2 are Active, not recruiting, and 5 are Enrolling by invitation. In total, there were 19 completed trials in Wroclaw Medical University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Wroclaw Medical University, 2 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".